The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 1,642 | 4,652,561 | SH | SOLE | 4,652,561 | 0 | 0 | ||
| AILERON THERAPEUTICS INC | COM | 00887A105 | 4,318 | 16,609,449 | SH | SOLE | 16,609,449 | 0 | 0 | ||
| AMERICAN WELL CORP | CL A | 03044L105 | 27,219 | 6,300,773 | SH | SOLE | 6,300,773 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 7,370 | 1,954,978 | SH | SOLE | 1,954,978 | 0 | 0 | ||
| AADI BIOSCIENCES INC | COM | 00032Q104 | 4,617 | 374,785 | SH | SOLE | 374,785 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 4,678 | 2,227,500 | SH | SOLE | 2,227,500 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 4,034 | 126,270 | SH | SOLE | 126,270 | 0 | 0 | ||